Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation

por Olivera, Pável, Velásquez-Escandón, César, Campoy, Desirée, Flores, Katia, Canals, Tania, Johansson, Erik, Herranz, María José, Martínez, Laia, Cerezo-Manchado, Juan José, Salinas, Ramón
Publicado 2023

Edoxaban Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Hospitalized Patients with Atrial Fibrillation and COVID-19 Infection

por Olivera, Pável E, Campoy, Desiree, Velasquez, César A, Flores, Katia, Canals, Tania, Johansson, Erik A, Martinez, Laia, Sierra, Jorge, Cerezo, Juan Jose, Salinas, Ramón
Publicado 2020

Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition

por Granell, Miquel, Calvo, Xavier, Garcia-Guiñón, Antoni, Escoda, Lourdes, Abella, Eugènia, Martínez, Clara Mª, Teixidó, Montserrat, Gimenez, Mª Teresa, Senín, Alicia, Sanz, Patricia, Campoy, Desirée, Vicent, Ana, Arenillas, Leonor, Rosiñol, Laura, Sierra, Jorge, Bladé, Joan, de Larrea, Carlos Fernández
Publicado 2017

Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the “ACO-VID” Registry

por Cerezo Manchado, Juan José, Iturbe Hernández, Teodoro, Martínez Pacheco, María del Carmen, Gil Ortega, Ignacio, Campoy, Desirée, Canals Pernas, Tania, Martinez Serra, Laia, Flores Aparco, Katia Jessica, Velasquez Escandon, Cesar Andres, García de Guadiana-Romualdo, Luis, Martinez Frances, Antonio, Olivera, Pavel
Publicado 2023